Material
†, ‡ NK cells are innate immune lymphocytes that can react to cells lacking self-MHC class I. However, NK cells that cannot engage self-MHC through an inhibitory receptor are resistant to stimulation through their activation receptors. To become licensed (i.e., functionally competent to be triggered through its activation receptors), an NK cell must engage host MHC class I via a MHC class Ispecific inhibitory receptor, such as a member of the murine Ly49 family. To explore potential determinants of NK cell licensing on a single Ly49 receptor, we have investigated the relative licensing impacts of the b, d, k, q, r, and s H2 haplotypes on Ly49A + NK cells. The results indicate that licensing is essentially analog but is saturated by moderate-binding MHC class I ligands. Interestingly, licensing exhibited a strong inverse correlation with a measure of cis engagement of Ly49A. Finally, licensing of Ly49A + NK cells was found to be less sensitive to MHC class I engagement than Ly49A-mediated effector inhibition, suggesting that licensing establishes a margin of safety against NK cell autoreactivity. The Journal of Immunology, 2010, 184: 000-000. N K cells are innate immune lymphocytes that produce proinflammatory cytokines and kill transformed and virally infected cells. Traditionally, NK cells are thought to recognize missing self, the lack of normal expression of MHC class I molecules (1) . For this purpose, murine NK cells express inhibitory receptors of the Ly49 C-type lectin superfamily, such as Ly49A, that dampen effector responses (2) . Like other inhibitory Ly49 receptors, Ly49A is expressed on a subset of NK cells. It is specific for some but not all MHC class I alleles (e.g., H2D
d and H2D k and not H2K b ) (3, 4) . That Ly49A interacts with H2D d is particularly well supported, including crystallographic information (5) , whereas Ly49A binding to other MHC class I alleles has been less thoroughly examined.
According to the missing-self hypothesis, NK cells in MHC class I-deficient mice should be autoreactive, as host MHC class I is unable to engage NK cell inhibitory receptors. However, NK cells that develop in MHC class I-deficient hosts (e.g., mice deficient for b 2 -microglobulin [b 2 m]), are hyporesponsive (i.e., they fail to produce cytokines or release cytotoxic effectors in response to activation receptor stimuli that elicit responses from wild-type NK cells) (6) . NK cells require engagement of an inhibitory receptor with MHC class I, such as Ly49A with H2D d , to attain functional competence (7, 8) . This process, termed licensing, allows NK cells to be activated through activation receptors to detect and kill cells lacking self-MHC class I. NK cells without self-MHC-specific inhibitory receptors remain unlicensed and hence are unable to react against MHC class I-deficient cells, thus avoiding autoreactivity. Licensing requires the cytoplasmic tail and specifically the ITIM of the self-MHC-specific inhibitory Ly49 receptor (7) . Thus, the NK cell inhibitory receptors have a second function in licensing or education of NK cells in self-tolerance.
More detailed knowledge of the contribution of individual NK cell inhibitory receptors to licensing in different MHC contexts may have clinical implications. Human NK cells display properties consistent with licensing in that NK cells expressing a killer Ig-like receptor (KIR) with specificity for self-HLA molecules exhibit more robust responsiveness than NK cells without self-HLA specific receptors in the same individual (9) (10) (11) . With increasing numbers of studies reporting a connection of NK cell inhibitory receptors and licensing with human antiviral and anticancer responses (12) (13) (14) , a better understanding of licensing in mice should provide insight into human NK cell biology and its effects on human health and disease.
Recent studies addressed the potency of NK cell subsets in mice expressing one, two, or three MHC class I alleles (15, 16) . Joncker et al. (16) reported that NK cell potency increases with the number of self-specific inhibitory receptors; NK cells expressing two different self-specific inhibitory receptors respond more robustly to stimulation than NK cell subsets expressing only one self-specific inhibitory receptor. Brodin et al. (15) used flow cytometry to assess the NK cell potency of Ly49-monopositive populations in mice expressing selected MHC class I alleles. They found that the Ly49A-monopositive NK cell subset of mice expressing only H2D d , a known licensing ligand for Ly49A (7), exhibited a more robust response to NKG2D stimulation than the corresponding cells from mice expressing only H2D b , which in turn responded more strongly than cells from mice lacking MHC class I. Based on these and other data, Brodin et al. (15) and Joncker et al. (16) propose a quantitative (rheostat) model of licensing, in which the potency of a given NK cell subpopulation is modulated by the nature and number of Ly49-MHC class I interactions. Data from studies of human NK cells also support a quantitative model of licensing. Yu et al. (11) and Yawata et al. (17) both report that NK cell potency was higher among NK cells that expressed two self-specific KIRs than among NK cells expressing only one selfspecific KIR. Thus, the available data support quantitative modulation of potency of an individual NK cell based upon the number of self-MHC-specific inhibitory receptors that it expresses.
On the other hand, evidence of the effect of engagement of a single inhibitory receptor by different MHC alleles is limited, although the simplest prediction of the rheostat model is that stronger interactions shouldproducemorepotentNKcells. However . Thus, only a very limited selection of MHC class I alleles has been used to study the putative quantitative nature of licensing through a single self-MHC-specific receptor, such as Ly49A.
To more thoroughly address whether a particular Ly49 receptor obeys a quantitative model of licensing, a larger and more diverse group of MHC class I alleles should be investigated. MHCcongenic mice on a C57BL/10 background represent an ideal model system in which to study NK cells in a variety of MHC class I contexts. These mice should all possess the same genetic background, including the same haplotype of the Ly49 gene family in the NK gene complex, which otherwise can display profound genetic differences between inbred strains of mice (19) . Moreover, these mice allow study of MHC class I alleles that have generally not been studied in detail in NK cell biology.
Interpretation of Ly49 function with respect to self-MHC alleles requires understanding of Ly49 specificities. Binding assays of Ly49Awith an array of MHC class I molecules have been published, but these studies feature several important limitations that were initially unappreciated. For example, Ly49A specificity was previously determined using MHC class I tetramers refolded with human b 2 m to bind Ly49A-transfected cells (3) . As the Ly49A binding site on MHC class I is now known to include b 2 m contact sites that are disrupted by human b 2 m (4, 20), these results must be interpreted with caution. Cell-cell adhesion assays of Ly49A-transfected cells with MHC-congenic Con A blasts have been used to assess binding of Ly49A to cells of more unusual MHC haplotypes (3). However, cell-cell adhesion assays are less quantitative; these data deserve reassessment with more precise molecular tools, like Ly49A tetramer binding. Indeed, Ly49A tetramers have been used to stain naive splenocytes from a number of different mouse strains (18) . However, these studies were limited to only a handful of MHC-congenic strains, with the remaining MHC haplotypes tested on cells from inbred strains with different genetic backgrounds, raising the possibility that unknown non-MHC-associated loci could influence the interaction. Regardless, these additional MHC alleles have not been examined in the context of licensing. Thus, although previous studies provided important groundwork on the MHC specificities of Ly49A, new studies are warranted to reassess Ly49A specificity and to correlate these specificities with licensing of Ly49A + NK cell populations.
In this study, we have investigated licensing of Ly49A + NK cells in MHC-congenic hosts in parallel with studies of Ly49A tetramer binding to the same MHC haplotypes. The strength of licensing of Ly49A + NK cells varied with MHC haplotype and was saturated by a relatively low level of Ly49A-MHC class I binding affinity. Interestingly, licensing of Ly49A + NK cells has a higher affinity/ avidity threshold than effector inhibition mediated by Ly49A. This difference in threshold may represent a safeguard against autoimmunity similar to the difference in threshold between T cell negative selection in the thymus and activation in the periphery. k class I locus. These mice were then compared with commercially obtained parental strains. For the B10.RIII F2 hybrid mouse experiments, we mated B10.RIII mice to C57BL/6 mice. The subsequent (B10. RIII 3 C57BL/6) F1 hybrid mice were sibling mated to produce F2 hybrid mice, which were then screened with microsatellite markers for the H2 locus and chromosome 10 from B10.RIII mice. Microsatellite markers used are described in Supplemental Table I . All mice were used in accordance with institutional guidelines for animal experimentation.
Materials and Methods

Mice
Abs and flow cytometry
The following Abs and reagents were purchased from BD Biosciences (San Jose, CA): Pacific Blue and PerCP Cy5.5 anti-CD3 (145-2C11); PerCP Cy5.5 anti-CD19 (1D3); APC and PE Cy7 anti-NK1.1 (PK136); Alexa 488, PE, or PE Cy7 anti-IFN-g (XMG1.2); FITC anti-H2D k (15-5-5) ; PE anti-H2D d (34-5-8S); and PE and APC streptavidin. Anti-Ly49A clones A1 and JR9 were produced from hybridomas as previously detailed (21, 22) , purified, and labeled with biotin or FITC using standard protocols. For gating on Ly49A-monopositive NK cells, the following Ab clones were used to exclude other inhibitory NK cell receptors: 4LO33 (anti-Ly49C; produced from a hybridoma kindly provided by Suzanne Lemieux, Institut National de la Recherche Scientifique-Institut Armand-Frappier, Laval, Quebec, Canada); 5E6 (anti-Ly49C/I; BD Biosciences); HBF-719 (anti-Ly49F; BD Biosciences); 4D11 (anti-Ly49G2; BD Biosciences; hybridoma from American Type Culture Collection, Manassas, VA); YLI-90 (anti-Ly49I; BD Biosciences); 16a11 (anti-NKG2A; eBioscience, San Diego, CA). The commercially available Abs were purchased in PE-conjugated form, except 4D11 (APC). Homemade 4LO33 and 4D11 were used in biotinylated form with streptavidin-PE. Anti-NK1.1 clone PK136 (American Type Culture Collection) was grown from the hybridoma and purified according to standard protocols. For flow cytometric analysis, RBC-lysed single-cell suspensions of splenocytes were stained in the presence of 2.4g2 supernatants. Samples were analyzed on an FACSCanto (BD Biosciences), and the data were analyzed using FlowJo (TreeStar, Ashland, OR).
Cytokine assays
Splenocytes were harvested and stimulated with PK136 (anti-NK1.1) mAbs essentially as previously described (7). Briefly, six-well tissue culturetreated plates were coated with 2 mg or 5 mg purified PK136 in 1 ml PBS. A total of 10 7 naive splenocytes were added to the washed plates and incubated at 37˚C and 5% CO 2 for 1 h and then further incubated in the presence of brefeldin A (GolgiPlug, BD Biosciences) for an additional 7 h. IFN-g was detected by intracellular cytokine staining and flow cytometry as described previously (23) .
Ly49A
+ lymphokine-activated killer cell preparation 2 ) ranged from 88.7-95.5% (mean 6 SD: 92.6 6 2.3%).
Cytotoxicity assays
Four-hour [ 51 Cr] release assays were performed according to standard protocols using day 9 Ly49A + or Ly49A 2 LAK cells as effectors. Con A blast target cells were produced by culturing MHC-congenic splenocytes in R10 plus 6 mg/ml Con A for 2 d.
Ly49A tetramer synthesis and binding assays
Recombinant soluble BirA-tagged Ly49A monomers were synthesized, purified, and refolded as previously described from a construct generously provided by N. Matsumoto (University of Tokyo, Tokyo, Japan) (18) . The monomers were tetramerized with APC-conjugated streptavidin (BD Biosciences) immediately prior to cell staining.
Statistical analysis
Statistical calculations were performed using GraphPad Prism software (GraphPad, La Jolla, CA). Statistical significance of differences between two groups was calculated using the unpaired two-tailed t test. Correlations between groups of values were analyzed using two-tailed correlation regression.
Results
Licensing of Ly49A
+ NK cells in MHC-congenic mice
The licensing status of NK cells must be determined functionally, as no molecular marker of licensed NK cells has yet been identified. In this study, we used a target cell-free system of ex vivo stimulation of naive splenocytes with immobilized mAbs against NK1.1, an activation receptor expressed on all NK cells of mice with the C57BL/6 and C57BL/10 backgrounds (23). Stimulation through NK1.1 allowed us to compare the activation of individual NK cells through a universally expressed NK cell activation receptor, unlike target cellbased stimulation assays, which activate NK cells through multiple receptors and pathways that are incompletely defined and may differ from NK cell to NK cell. Furthermore, NK1.1 expression was not affected by MHC haplotype (data not shown). In the ex vivo NK1.1 stimulation assay, a higher frequency of licensed NK cells produce IFN-g, whereas few unlicensed NK cells produce IFN-g (7). IFN-g production by bulk Ly49A + NK cells as well as Ly49A- Table  I ). (For comparison, IFN-g production by the corresponding NK cell populations lacking Ly49A in addition to other inhibitory Ly49 and NKG2A receptors is shown in Supplemental Fig. 1B MHC haplotypes do not produce IFN-g at a higher frequency than the corresponding Ly49A 2 populations (Fig. 1B, Supplemental Fig. 1B ).
Conventionally, this would argue against a licensing impact of Ly49A in these MHC haplotypes. However, recent work indicates that unengaged Ly49A receptors actually suppress NK cell responsiveness to stimulation (26 Fig. 3B . Numerical values for the data shown in these figures are displayed in Table I . pp , 0.05; ppp , 0.01. susceptibility to models of arthritis, independent of the MHC locus (27, 28) . To test whether this genetic contamination was responsible for the observed high frequency of IFN-g production by B10.RIII NK cells, we crossed B10.RIII mice with C57BL/6 mice to produce F2 hybrid mice that were homozygous for RIII-derived genetic segments on either chromosome 10 or at the MHC locus. Such mice were identified by genotyping of microsatellite markers. In the PK136 stimulation assay, Ly49A
+ NK cells from mice of the H2 r MHC haplotype but lacking the RIII-derived chromosome 10 region produced IFN-g at a similar frequency to mice encoding both RIII-derived regions (Fig. 2) Ly49A and MHC class I molecules can also interact in cis (i.e., on the surface of the same cell) (29, 30) k approaching saturation (Fig. 3B) . Similar results were obtained with a second anti-Ly49A mAb, JR9, that is partially blocked by cis engagement of Ly49A and MHC class I (Supplemental Fig. 2) (30) . With either Ab, the results suggest that cis interactions of Ly49A with various MHC haplotypes are analog in character because, like tetramer binding, nearly all pairwise comparisons of MHC haplotypes produce a statistically significant difference. However, the differences between the MHC haplotypes with the lowest Ly49A surface accessibility were very small in magnitude, suggesting that these haplotypes had reached saturation of cis binding.
Interestingly, putative cis engagements of Ly49Awith MHC class I correlate better with strength of licensing than does Ly49A tetramer binding, a measure of trans interactions (R 2 = 0.83 and 0.31, respectively) (Fig. 3C, 3D ). In particular, NK cell licensing and cis engagement of Ly49A have similar saturation thresholds, suggesting that cis interactions of Ly49A with MHC class I is a strong determinant of licensing, as recently proposed by Chalifour et al. (26) (Fig. 4A) . Accordingly, D d tg/tg cells also bind more soluble Ly49A tetramer than D d tg/2 cells (Fig. 4B) . However, the licensing of Ly49A + NK cells from D d tg/tg and D d tg/2 mice was not significantly different (Fig. 4C, Supplemental Fig. 3A ). As expected, H2 k/k cells express twice the level of H2D k as H2 k/2 cells and also bind more soluble Ly49A tetramer (Fig. 4E, 4F ). However, there was no consistent statistically significant difference in licensing among Ly49A + NK cells (Fig. 4G, Supplemental Fig. 3B) . Furthermore, cis engagement of Ly49Awas similar in both H2 k/k and H2 k/2 Ly49A + NK cells (Fig.  4H ), indicating that, as in the MHC-congenic system above, cis engagement of Ly49A has the same saturation threshold as NK cell licensing. Together, these results indicate that haploinsufficiency of self-MHC has little or no effect on NK cell licensing, further supporting a low saturation threshold for NK cell licensing.
Different thresholds of licensing and effector inhibition mediated by Ly49A
Ly49A has two functions on NK cells: 1) licensing; and 2) inhibition of effector function (i.e., the inhibition of target cell cytotoxicity in the presence of a target cell ligand for Ly49A). To determine if effector inhibitioncorrelateswithMHChaplotypeinthesamewayaslicensing, we assessed inhibition of Ly49A + effector cells by Con A-activated blasts from MHC-congenic mice. We considered using naive NK cells and/or CD107a-based degranulation assays, but we determined that these approaches are not robust enough against Con A blast target cells to provide meaningful results. For these reasons, we chose to assess effector inhibition using traditional [ Cr] release assays with MHC-congenic Con Aactivated splenocytes as target cells (Fig. 5A) . To more easily visualize the data, we converted the percent specific lysis data to percent MHC-specific inhibition, normalizing to MHC class I-deficient cells (Fig. 5B) . This inhibition is Ly49A dependent, because Ly49A 2 LAKs failed to produce a similar pattern of inhibition and addition of a blocking Ab against Ly49A restored Ly49A + LAK killing of the MHC-congenic target cells (Supplemental Fig. 4) .
Interestingly, the relative levels of Ly49A-mediated effector inhibition by different MHC haplotypes produced the same hierarchy of NK cell licensing (Fig. 5) . However, we also observed some differences from NK cell licensing. For example, the H2 q haplotype robustly inhibited LAK killing yet had only a weak licensing effect (Fig. 1) . Similarly, the H2 s haplotype, which showed minimal licensing of Ly49A + NK cells, still inhibited Ly49A + LAK killing significantly more than the H2 b MHC haplotype (Fig. 5B) . These apparently different thresholds suggest that NK cell licensing and effector inhibition use separate molecular signaling pathways or, if mediated by the same signaling cascades, are controlled by differential threshold mechanisms. In addition, target cells hemizygous for an MHC class I ligand of Ly49A inhibited killing by Ly49A + LAKs as well as their homozygous counterparts (Fig. 5C, 5D ), indicating that effector inhibition, like licensing, is saturated by relatively low MHC class I avidity. . Specifically, the experiments presented in this study provide insight into the quantitative versus qualitative (onoff) nature of licensing of NK cells through a single Ly49 receptor. Moreover, the data provide evidence for Ly49A specificity for other MHC alleles.
Because NK cells may express more than one inhibitory receptor that may contribute to licensing, we need to consider the possibility that additional Ly49 receptors could influence the effects of the different MHC alleles on Ly49A + NK cells. However, such effects are likely to be limited for several reasons. First, other Ly49 family members are generally expressed on individual NK cells in a stochastic manner such that only a fraction of Ly49A + NK cells express another given Ly49 receptor. Second, in C57BL/6 mice that have the same Ly49 gene complex as C57BL/10 mice (31), there are five potential inhibitory Ly49 receptors (Ly49A, C, F, G, and I) expressed on adult NK cells. Other Ly49 genes encode activation receptors (Ly49D and H), are primarily expressed on fetal NK cells (Ly49E) (32) , are pseudogenes (Ly49J, K, L, and N) (33) , or expressed on non-NK cells (Ly49Q) (34) . When we studied monopositive-Ly49A + NK cells, by gating out all cells bearing other Ly49 receptors known to be expressed on adult NK cells (Ly49C, F, G, and I) as well as NKG2A, we obtained data that are essentially indistinguishable from those without deliberate gating out of Ly49C/F/G/I/NKG2A + cells. Third, MHC specificity for Ly49A was also assessed by killing assays against Con A blasts from the same MHC-congenic mice. In these studies, we demonstrated that Ly49A has essentially the same hierarchy of MHC specificity as licensing of Ly49A + NK cells. In the killing assays, Ly49A specificity was also verified by anti-Ly49A blocking Abs, which reversed the Ly49A-mediated, MHC-dependent inhibition. Finally, Ly49A tetramer binding to splenocytes from the same MHC-congenic mice also provided essentially the same hierarchy as the licensing effects. Therefore, the data indicate that a particular NK cell receptor exhibits different potencies on licensing, depending on the MHC class I context, and that NK cell licensing through a given receptor exhibits a low threshold for saturation.
Taken together, our findings are largely consistent with a quantitative (rheostat) model of NK cell licensing, with several new and importantprinciples.First,NKcelllicensing issaturatedbya relatively low apparent affinity and avidity of Ly49A engagement, as determined by Ly49A tetramer binding. This is best exemplified by the H2 moderate-binding MHC haplotype H2 k , did not affect strength of licensing, indicating that the saturation threshold of Ly49A-mediated licensing encompasses low-avidity interactions.
Previous data regarding a saturation threshold for NK cell licensing were inconclusive when the effects of H2 b and H2 d alleles were studied. Joncker et al. (16) reported increased NK cell potency with up to three simultaneously expressed self-specific inhibitory receptors. However, Brodin et al. (15) observed saturation of NK cell licensing by NK cells from H2 b mice that expressed three self-specific receptors; these NK cells were not more potent than NK cells expressing two of the three receptors. On the other hand, the inclusion of two additional receptors (i.e., the very small population of NK cells that expresses five inhibitory receptors) produced a boosted response to stimulation. In contrast, our data with additional MHC alleles demonstrate that licensing through Ly49A has an affinity-based saturation threshold when examined in different MHC contexts. Additional studies are needed to determine if this phenomenon is generalizable to other MHC class I-specific inhibitory receptors, which have different MHC specificities from Ly49A.
Interestingly, Ly49A surface accessibility by anti-Ly49A mAbs, a surrogate measure of cis interactions of Ly49A and MHC class I (30), exhibited a much stronger correlation with NK cell licensing than did measures of trans interactions. Importantly, the saturation pattern of putative Ly49A cis engagements coincided with that of licensing of Ly49A + NK cells. We cannot formally rule out that the observed pattern of anti-Ly49A Ab binding is due to actual differences in Ly49A surface expression. However, when interpreted as measures of cis engagements, as previously described, these findings are consistent with a recent study by Chalifour et al. (26) , which reported that cis interactions, but not trans interactions, of Ly49A and H2D d or H2D k are required for licensing. Indeed, our data provide additional evidence for an important role for cis interactions in licensing and extend previous observations to additional MHC haplotypes. The low threshold for saturation of cis interactions may be due to differences in relative surface expression levels of MHC class I and Ly49A. In studies of MHC class I (H2D d ) transfer from donor cells to Ly49A + NK cells, H2D d levels reached a maximum of 16-30% of endogenous levels (35, 36) . These data suggest that endogenous MHC class I molecules outnumber Ly49A receptors by several-fold on the surface of NK cells. For cis engagement with Ly49A, high avidity may compensate for the moderate affinity of some MHC class I molecules for Ly49A such that even moderate Ly49A ligands induce full saturation of cis engagement. Furthermore, if cis binding determines licensing, and cis binding is overwhelmed by the number of MHC class I molecules, then decreasing the number of MHC class I molecules while maintaining the same affinity should not significantly affect licensing. Indeed, these are the results observed in Ly49A + NK cells from mice expressing one versus two copies of an H2D d transgene or endogenous H2 k class I locus. Future quantitative studies are needed to confirm this hypothesis.
In humans, genotyping analysis reveals an epidemiological association between disease outcomes and certain KIR and HLA allele pairs that can potentially be explained by licensing (37) . For example, resolution of hepatitis C viral infection is associated with homozygosity of genotypes for both KIR2DL3 and its HLA ligand (38 + transfectants bind to cells transfected with a specific MHC allele. Again, adhesion is blocked by Abs against Ly49A or the MHC allele. Similarly, Ly49A or MHC class I tetramers bind cells expressing the cognate partner. Although all of these assays have their strengths and weaknesses, it is probably most important to note that Ly49A binding to MHC class I is through a site under the peptide binding domain, involving a1, a2, and a3 of the H chain as well as b 2 m (20) . The b 2 m residues are species-specific such that human b 2 m cannot be bound by Ly49A (4, 20) , which affects interpretation of prior data with tetramers of MHC class I refolded with human b 2 m. Moreover, binding studies using cells overexpressing either cognate partner by transfection may not fully recapitulate physiological binding of receptors and ligands expressed at native levels. With these caveats, it should be noted that we provide in this study information on new ligands for Ly49A based on more physiological assays of licensing and inhibition of cytotoxicity. Although we have not yet identified the exact MHC class I allele(s) responsible for Ly49A interaction in the H2 r , H2 q , and H2 s haplotypes, these considerations do reinforce the notion that Ly49A specificities may need to be considered in physiological contexts and that other assays of MHC specificities could be misleading.
Another interesting finding relates licensing to the function of inhibitory receptors like Ly49A in inhibition of effector functions, such as cytotoxicity (21, 40) . Interestingly, Ly49A-dependent effector inhibition is even more sensitive to MHC class I engagement than is Ly49A-mediated NK cell licensing. This is best demonstrated by H2 q , a MHC haplotype that can strongly inhibit cytotoxicity by Ly49A + LAK cells yet produces only poorly licensed NK cells. In other words, the threshold of MHC class I engagement required for inhibition of effector function is lower than for NK cell licensing. Some caution should be exercised in comparing assays that use different output measures (i.e., cytokine production versus cytotoxicity). It is also possible that IL-2 activation affects the stimulation threshold of the NK cells, although similar effects likely occur during the proinflammatory phase of initial immune responses. Nonetheless, these findings reveal an interesting relationship between licensing and NK cell effector function.
The apparent differences in activation thresholds of NK cell licensing and effector function are reminiscent of T cell tolerance, in which the signal threshold for negative selection in the thymus is lower than for activation in the periphery (41) (42) (43) (44) . In this way, all T cells that have any chance of reacting to self-Ags in the periphery are deleted. A similar safeguard may govern the licensing of NK cells such that only NK cells capable of achieving a strong interaction with self-MHC become licensed. A more sensitive threshold of inhibition in the periphery ensures that licensed NK cells maintain tolerance to healthy self-cells.
The difference in threshold of NK cell licensing and effector inhibition has important implications for our understanding of the signaling cascades that mediate these events. Although Ly49A-mediated effector inhibition relies mainly upon signaling initiated by Src homology region 2 domain-containing phosphatase 1, the precise signaling pathway required for licensing remains unclear (45) (46) (47) . However, the differences in threshold support the view that different signaling events or outcomes may underlie these two functions of Ly49A. Although the ITIM is known to be required for both NK cell licensing and effector inhibition, it is increasingly evident that ITIMs can initiate a number of diverse signaling cascades (48, 49) . Alternatively, similar molecular signaling mediators may be used but with a differentially regulated threshold mechanism. Both possibilities lead to further questions of how such a differential signaling or threshold mechanism might be regulated. In teleological terms, how does an NK cell know the difference between licensing and effector inhibition? These issues warrant further study.
